![](/img/cover-not-exists.png)
Dexmedetomidine suppresses the progression of esophageal cancer via miR-143-3p/epidermal growth factor receptor pathway substrate 8 axis
Zhang, Peisen, He, Hefan, Bai, Yuyan, Liu, Weifeng, Huang, LirongVolume:
31
Journal:
Anti-Cancer Drugs
DOI:
10.1097/CAD.0000000000000934
Date:
August, 2020
File:
PDF, 1.87 MB
2020